Food and Drug Administration

Anti-Infective Drugs Advisory Committee

March 5, 2003


Associated Antibiotic Resistance Among Common Hospital - and Community-Acquired Bacterial Pathogens, Dr. James Jorgensen, PhD (HTM) (PPT)

Development of Drugs for Resistant Organisms, Dr. Francis Tally, MD, Cubist Pharmaceuticals, Inc. (HTM) (PPT)

Listing Antimicrobial Resistant Pathogens of Public Health Importance - Implications for Drug Development, Dr. John Powers, MD, FDA (HTM) (PPT)

How Clinicians Use Data For Clinical Decision Making, Dr. John Bradley, MD, Children's Hospital San Diego (HTM) (PPT)

Data From Studies in One Indication Supporting Studies in a Different Indication, Dr. Edward Cox, MD, MPH, FDA (HTM) (PPT)

Points for Discussion (HTM) (PPT)